Creative Medical Technology Holdings Inc
Clinical trials sponsored by Creative Medical Technology Holdings Inc, explained in plain language.
-
New cell therapy aims to tame type 1 diabetes early
Disease control Recruiting nowThis early-stage study tests a new treatment called CELZ-201 for people recently diagnosed with type 1 diabetes. The goal is to see if it is safe and can help preserve the body's ability to make some insulin. The study involves 18 adults aged 18 to 35 who have had diabetes for le…
Phase: PHASE1, PHASE2 • Sponsor: Creative Medical Technology Holdings Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New shot aims to ease back pain without surgery
Symptom relief Recruiting nowThis study tests a new medicine called CELZ-201-DDT, given as a shot into the back muscles, for people with long-term lower back pain caused by worn-out discs. The goal is to see if it is safe and can reduce pain and improve movement. About 45 adults aged 18-80 who have not gotte…
Phase: PHASE1, PHASE2 • Sponsor: Creative Medical Technology Holdings Inc • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC